Are you able to shed more light on the following stmt that "on 9/15/09 PARD announced that 320 evaluable events (patient deaths) occured in its pivotal phase 111 trial"
Does this mean that 320 people died while on PARD trial drugs? If so how does did impact ongoing research of their pipeline